Previous Article | Next Article 
Mol Cell Biol. 1990 May; 10(5): 1901-1907
Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population.
T J McDonnell,
G Nunez,
F M Platt,
D Hockenberry,
L London,
J P McKearn and
S J Korsmeyer
Howard Hughes Medical Institute, St. Louis, Missouri.
ABSTRACT
We characterized the basis for the follicular lymphoproliferation in transgenic mice bearing a Bcl-2-immunoglobulin (Bcl-2-Ig) minigene representing the t(14;18) of human follicular lymphoma. Discriminatory S1 nuclease protection assays revealed that the Bcl-2-Ig transgene was overexpressed relative to endogenous mouse Bcl-2 in spleen and thymus. Western (immunoblot) analysis demonstrated the overproduction of the human 25-kilodalton Bcl-2 protein, which arose from the transgene, in spleen, thymus, and the expanded B-cell subset. Despite the generalized lymphoid pattern of deregulation, two-color flow cytometry and density gradient centrifugation indicated that the expanded lymphocytes were predominantly small, resting B cells coexpressing B220, immunoglobulin M (IgM), IgD, Ia, and kappa. Cell cycle analysis confirmed that about 97% of these expanded B cells reside in G0/G1. An extensive characterization of transgenic lines revealed a fourfold excess of IgM-IgD-expressing B cells in spleen and dramatically increased numbers in bone marrow. While resting, these cells proliferated in response to lipopolysaccharide and anti-IgM and demonstrated normal B-cell colony formation in soft agar. Moreover, these B cells, which demonstrated an extended survival in vitro even in the absence of stroma, were also resting in G0, yet were capable of proliferative responses. These findings provide consistent evidence that the accumulation of B cells after Bcl-2 overproduction is secondary to prolonged cell survival and not increased cell cycling. This suggests a unique role for Bcl-2 as a proto-oncogene that enhances cell survival independent of promoting cell division.
Mol Cell Biol. 1990 May; 10(5): 1901-1907
This article has been cited by other articles:
-
Chattopadhyay, G., Khan, A. Q., Sen, G., Colino, J., duBois, W., Rubtsov, A., Torres, R. M., Potter, M., Snapper, C. M.
(2007). Transgenic Expression of Bcl-xL or Bcl-2 by Murine B Cells Enhances the In Vivo Antipolysaccharide, but Not Antiprotein, Response to Intact Streptococcus pneumoniae. J. Immunol.
179: 7523-7534
[Abstract]
[Full Text]
-
Iqbal, J., Neppalli, V. T., Wright, G., Dave, B. J., Horsman, D. E., Rosenwald, A., Lynch, J., Hans, C. P., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Campo, E., Ott, G., Muller-Hermelink, H. K., Delabie, J., Jaffe, E. S., Grogan, T. M., Connors, J. M., Vose, J. M., Armitage, J. O., Staudt, L. M., Chan, W. C.
(2006). BCL2 Expression Is a Prognostic Marker for the Activated B-Cell-Like Type of Diffuse Large B-Cell Lymphoma. JCO
24: 961-968
[Abstract]
[Full Text]
-
Yeh, T.-Y., Chuang, J.-Z., Sung, C.-H.
(2005). Dynein light chain rp3 acts as a nuclear matrix-associated transcriptional modulator in a dynein-independent pathway. J. Cell Sci.
118: 3431-3443
[Abstract]
[Full Text]
-
Langenau, D. M., Jette, C., Berghmans, S., Palomero, T., Kanki, J. P., Kutok, J. L., Look, A. T.
(2005). Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. Blood
105: 3278-3285
[Abstract]
[Full Text]
-
Donahue, A. C., Hess, K. L., Ng, K. L., Fruman, D. A.
(2004). Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85{alpha}. Int Immunol
16: 1789-1798
[Abstract]
[Full Text]
-
Rahman, Z. S. M., Manser, T.
(2004). B Cells Expressing Bcl-2 and a Signaling-Impaired BAFF-Specific Receptor Fail to Mature and Are Deficient in the Formation of Lymphoid Follicles and Germinal Centers. J. Immunol.
173: 6179-6188
[Abstract]
[Full Text]
-
Sanchez-Beato, M., Sanchez-Aguilera, A., Piris, M. A.
(2003). Cell cycle deregulation in B-cell lymphomas. Blood
101: 1220-1235
[Abstract]
[Full Text]
-
Cancro, M. P., Sah, A. P., Levy, S. L., Allman, D. M., Schmidt, M. R., Woodland, R. T.
(2001). xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development. Int Immunol
13: 1501-1514
[Abstract]
[Full Text]
-
Zhou, P., Levy, N. B., Xie, H., Qian, L., Lee, C.-Y. G., Gascoyne, R. D., Craig, R. W.
(2001). MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood
97: 3902-3909
[Abstract]
[Full Text]
-
Willis, T. G., Dyer, M. J. S.
(2000). The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood
96: 808-822
[Full Text]
-
Waters, J. S., Webb, A., Cunningham, D., Clarke, P. A., Raynaud, F., di Stefano, F., Cotter, F. E.
(2000). Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin's Lymphoma. JCO
18: 1812-1823
[Abstract]
[Full Text]
-
Hsu, S. Y., Hsueh, A. J. W.
(2000). Tissue-Specific Bcl-2 Protein Partners in Apoptosis: An Ovarian Paradigm. Physiol. Rev.
80: 593-614
[Abstract]
[Full Text]
-
Jacobs, J. J.L., Scheijen, B., Voncken, J.-W., Kieboom, K., Berns, A., van Lohuizen, M.
(1999). Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev.
13: 2678-2690
[Abstract]
[Full Text]
-
Doostzadeh-Cizeron, J., Evans, R., Yin, S., Goodrich, D. W.
(1999). Apoptosis Induced by the Nuclear Death Domain Protein p84N5 Is Inhibited by Association with Rb Protein. Mol. Biol. Cell
10: 3251-3261
[Abstract]
[Full Text]
-
Macpherson, N., Lesack, D., Klasa, R., Horsman, D., Connors, J. M., Barnett, M., Gascoyne, R. D.
(1999). Small Noncleaved, Non-Burkitt's (Burkitt-Like) Lymphoma: Cytogenetics Predict Outcome and Reflect Clinical Presentation. JCO
17: 1558-1558
[Abstract]
[Full Text]
-
Lapointe, J., Fournier, A., Richard, V., Labrie, C.
(1999). Androgens Down-Regulate bcl-2 Protooncogene Expression in ZR-75-1 Human Breast Cancer Cells. Endocrinology
140: 416-421
[Abstract]
[Full Text]
-
Zhou, P., Qian, L., Bieszczad, C. K., Noelle, R., Binder, M., Levy, N. B., Craig, R. W.
(1998). Mcl-1 in Transgenic Mice Promotes Survival in a Spectrum of Hematopoietic Cell Types and Immortalization in the Myeloid Lineage. Blood
92: 3226-3239
[Abstract]
[Full Text]
-
Middleton, G., G. P. Pinon, L., Wyatt, S., Davies, A. M.
(1998). Bcl-2 Accelerates the Maturation of Early Sensory Neurons. J. Neurosci.
18: 3344-3350
[Abstract]
[Full Text]
-
Wang, D.-G., Johnston, C. F., Marley, J. J., Phenix, K. V., Atkinson, A. B., Russell, C. F. J., Buchanan, K. D.
(1997). Expression of the Apoptosis-Suppressing Gene BCL-2 in Pheochromocytoma is Associated with the Expression of C-MYC. J. Clin. Endocrinol. Metab.
82: 1949-1952
[Abstract]
[Full Text]
-
Pinon, L., Middleton, G, Davies, A.
(1997). Bcl-2 is required for cranial sensory neuron survival at defined stages of embryonic development. Development
124: 4173-4178
[Abstract]
-
Furuchi, T, Masuko, K, Nishimune, Y, Obinata, M, Matsui, Y
(1996). Inhibition of testicular germ cell apoptosis and differentiation in mice misexpressing Bcl-2 in spermatogonia. Development
122: 1703-1709
[Abstract]
-
Chen, Y Y, Wang, L C, Huang, M S, Rosenberg, N
(1994). An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.. Genes Dev.
8: 688-697
[Abstract]
-
Merry, D., Veis, D., Hickey, W., Korsmeyer, S.
(1994). bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development
120: 301-311
[Abstract]
-
Adams, J., Cory, S
(1991). Transgenic models of tumor development. Science
254: 1161-1167
[Abstract]
Copyright © 1990 by the American Society for Microbiology. All rights reserved.